Case 1: Personal Approach to Treatment for Acute GVHD Targeted Oncology 5:33 4 years ago 158 Далее Скачать
Case 1: Treating Acute Graft-Versus-Host Disease Targeted Oncology 2:56 4 years ago 127 Далее Скачать
Case 1: A Patient With Acute Graft-Vs-Host Disease Targeted Oncology 2:39 4 years ago 466 Далее Скачать
Initial, Steroid-Refractory, and Novel Treatment Options for GVHD Targeted Oncology 5:29 4 years ago 49 Далее Скачать
Case 2: Steroid-Refractory Acute Graft-Versus-Host Disease Targeted Oncology 2:24 4 years ago 102 Далее Скачать
Management of acute and chronic GvHD VJHemOnc – Video Journal of Hematology & HemOnc 4:26 4 years ago 905 Далее Скачать
Case 3: Treating Moderate Chronic Graft-Versus-Host Disease Targeted Oncology 8:27 4 years ago 74 Далее Скачать
Vedolizumab for GI acute GvHD prophylaxis after allogeneic transplantation VJHemOnc – Video Journal of Hematology & HemOnc 0:42 1 year ago 214 Далее Скачать
Case 3: Moderate Chronic Graft-Versus-Host Disease Targeted Oncology 2:28 4 years ago 105 Далее Скачать
GVHD in 2022: from prevention to therapy International Academy for Clinical Hematology IACH 50:25 2 years ago 1 038 Далее Скачать
Case 3: Ruxolitinib for Steroid-Refractory Acute GVHD Targeted Oncology 4:03 4 years ago 122 Далее Скачать
Case 3: Treating Chronic Graft-Versus-Host Disease Targeted Oncology 3:35 4 years ago 66 Далее Скачать
Overcoming the Challenges of Acute and Chronic GVHD PeerView Oncology 56:36 2 years ago 2 389 Далее Скачать
Biomarker testing may transform treatment of acute GVHD (Part 1) MDedge: news and insights for busy physicians 4:09 5 years ago 217 Далее Скачать
